Ken Griffin Tiziana Life Sciences LTD Call Options Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.63 - $1.69 $15,120 - $40,560
24,000 New
24,000 $25,000
Q3 2024

Nov 14, 2024
BUY
$0.81 - $1.45 $15,552 - $27,840
19,200 New
19,200 $18,000
Q4 2023

Feb 14, 2024
BUY
$0.55 - $0.85 $6,545 - $10,115
11,900 New
11,900 $6,000

Others Institutions Holding TLSA

# of Institutions
34
Shares Held
4.61M
Call Options Held
0
Put Options Held
0
View Full List

About Tiziana Life Sciences Ltd

TLSA Quotes by TradingView
  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $201M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email